Lv2
140 积分 2024-07-25 加入
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
26分钟前
已完结
First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer
3天前
已完结
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents A Phase 3 Randomized Clinical Trial
3个月前
已关闭
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents A Phase 3 Randomized Clinical Trial
3个月前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
3个月前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
4个月前
已完结
The design and discovery of phospholipase A2 inhibitors for the treatment of inflammatory diseases
4个月前
已完结
GSK's darapladib failures dim hopes for anti-inflammatory heart drugs
4个月前
已完结
Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome The SOLID-TIMI 52 Randomized Clinical Trial
4个月前
已完结
Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant: A Randomized Clinical Trial
4个月前
已关闭
皖公网安备34019202002308
